Investors entering the landscape of venture capital are often bombarded with acronyms for terms that can seem foreign. While a general understanding of the concept that the term represents can be understood by context, knowing the complete meaning of these terms can provide powerful insight into better understanding the return profile of an investment and help make better informed investments. In this paper, we hope to elucidate some commonly used acronyms and the concepts behind them in order to make the world of VC more accessible to anyone approaching it.
Continue Reading >We're thrilled to share that Bioverge hosted an Ask Me Anything (AMA) session on July 20, 2023, where we dove into the depths of biotech and healthcare venture capital. During the AMA session, our CEO Neil Littman addressed ...
Continue Reading >One little girl opened my eyes to the awe-inspiring innovative possibilities emerging in healthcare and biotechnology. Every day we’re seeing profound breakthroughs in biological research that are rapidly transforming our understanding of disease and the human body. Equally exciting are advancements in technology in computing and beyond. In biotech, the ...
Continue Reading >Presenting the Venture Capital 101 whitepaper highlighting the background and basics of VC for potential investors.
Continue Reading >Volumetric has entered into an agreement for acquisition by 3D Systems for up to $400M.
Continue Reading >For retail investors, it has only become possible to invest in startups and private companies over the last 1-2 decades. This is largely the result of new legislation like Regulation CF and the proliferation of startup investing platforms. Prior to this, only well-connected investors with a significant net worth had the opportunity to invest in these companies.
Continue Reading >The investing world is rapidly evolving. Investors can now invest in private healthcare and biotech companies that were once the exclusive domain of professional investors.
Continue Reading >Healthcare provides another avenue in which investors can do well by doing good.
Continue Reading >CELLINK has entered into an agreement to acquire Discover Echo Inc., an innovative and revolutionary microscopy company, for $110M.
Continue Reading >Impact investing is both financially and socially rewarding, providing benefits to the individual investor and the world at large.
Continue Reading >